Publications by authors named "Yufeng Cheng"

Claim this Profile
A
A "production-emission-pollution" approach for quantifying contribution of multiple driving factors to nitrogen pollution generation in Guangzhou city of China.
Ao Wei, Yanpeng Cai, Yufeng Cheng, Shunyu Zhao, Yelin Wang

J Environ Manage· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on the Diagnosis and Treatment of Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer.
Xiangjiao Meng, Nan Bi, Jun Wang, Xue Meng, Jianbo Wang, Yufeng Cheng

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLC.
Youling Gong, Qingsong Pang, Rong Yu, Zhengfei Zhu, Jiangqiong Huang, Yufeng Cheng

JTO Clin Res Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tRNA-derived fragment tRF-24 drives CELF1 phase separation to promote oncogenic splicing in esophageal squamous cell carcinoma.
Yajie Hu, Xin Qin, Li Gong, Ling Pan, Yufeng Cheng

J Exp Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy.
Hongyuan Mao, Jinyue Li, Chenhan Huang, Zerun Li, Xinyue Ma, Bo Cheng, Yufeng Cheng

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated single-cell and Mendelian randomization analyses: dissecting underlying causes of varied efficacy in immune neoadjuvant therapy for esophageal carcinoma.
Jiaxin Li, Sibo Meng, Ying Zhou, Yufeng Cheng

Discov Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tRNA-Derived Fragment tRF-22 Promotes Immunosuppression by Inhibiting HnRNPAB Ubiquitination in Esophageal Squamous Cell Carcinoma.
Ling Pan, Xin Qin, Li Gong, Haining Liu, Bo Cheng, Yufeng Cheng

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARL5B Drives Esophageal Squamous Cell Carcinoma Progression via ROCK1-SREBP1-Mediated Lipid Metabolic Reprogramming.
Xinyue Ma, Yanfei Sun, Hongyuan Mao, Chenhan Huang, Zerun Li, Bo Cheng, Yufeng Cheng

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis.
Yufeng Cheng, Guoqing Wang, Xinxing Yang, Yuanyuan Wang, Daidi Li

Pharmacol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavy Metals Toxicity: Mechanism, Health Effects, and Therapeutic Interventions.
Yu-Feng Cheng, Yu-Jia Zhao, Ce Chen, Feng Zhang

MedComm (2020)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression.
Aijie Yang, Haiyun Song, Yufeng Cheng

Cancer Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and validation of a necroptosis-related lncRNA signature for predicting the prognosis of gastrointestinal cancer patients.
Weicheng Huang, Yuchen Liu, Ruyi Liu, Chi Feng, Jiehua Wu, Yufeng Cheng

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side effects of boron neutron capture therapy.
Yushu Zhang, Yufeng Cheng

J Cancer Res Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metallothionein and neurodegenerative diseases.
Yufeng Cheng, Yujia Zhao, Ce Chen, Feng Zhang

Neural Regen Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAMA3 overexpression enhances proliferation, migration and invasion in esophageal squamous cell carcinoma based on bioinformatics and experimental validation.
Xia Wu, Qian Li, Junbin Wang, Lei Li, Mingtang Zuo, Yufeng Cheng

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing NKG2D CAR-T cells with radiotherapy: a novel approach for esophageal squamous cell carcinoma treatment.
Tianyu Liu, Liyuan Fan, Weicheng Huang, Pengxiang Chen, Yuchen Liu, Yufeng Cheng

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers.
Ruyi Liu, Yuchen Liu, Weicheng Huang, Pengxiang Chen, Yufeng Cheng

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akkermansia muciniphila protects against dopamine neurotoxicity by modulating butyrate to inhibit microglia-mediated neuroinflammation.
Kaifei Xu, Guoqing Wang, Jiantao Gong, Xinxing Yang, Yufeng Cheng

Int Immunopharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging roles of angiopoietin‑like 4 in human tumors (Review).
Ruyi Liu, Miaomiao Fu, Pengxiang Chen, Yuchen Liu, Weicheng Huang, Yufeng Cheng

Int J Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced resistance to drug-induced liver injury using glycyrrhetinic acid modified-transferrin nanoparticles loading hepatocyte growth factor.
Xin Cui, Weilin Wang, Yufeng Cheng, Shasha Li, Fei Li

Biomed Mater· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tRNA-derived small RNAs (tsRNAs): establishing their dominance in the regulation of human cancer.
Li Gong, Yajie Hu, Ling Pan, Yufeng Cheng

Front Genet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial.
Baiqiang Dong, Long Chen, Qingsong Pang, Ou Jiang, Hong Ge, Yufeng Cheng

Transl Lung Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Shengxiang Ren, Anwen Xiong, Jia Yu, Xicheng Wang, Baohui Han, Yufeng Cheng, Ying Cheng

Cancer Immunol Immunother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retracted: Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance.
Wei Wei, Yanqin Wang, Xiaoming Yu, Lan Ye, Yuhua Jiang, Yufeng Cheng

Med Sci Monit· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial.
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Ying Cheng

J Immunother Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis